Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Brand

Showing results (111-120 of 163) with videos related to

Pageof 17
Sort By:
Pharmacoepidemiology and Drug Safety|May 3, 2014
Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodiesFlorian Beigel, Anni Steinborn, Fabian Schnitzler, et al.
Scientific Reports|June 20, 2025
CCL20 expression is elevated in inflammatory bowel disease and attenuated by vitamin D metabolitesJohannes Stallhofer, Felix Reichl, Michael Lauseker, et al.
Journal of Crohn'S & Colitis|June 28, 2020
Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should knowPhilipp Schreiner, Nicolas J Mueller, Jan Fehr, et al.
United European Gastroenterology Journal|September 9, 2024
Fecal urgency and incontinence in inflammatory bowel disease perceived by physician and patient: Results from the Swiss fecal urgency surveyNadia Wespi, Stephan Vavricka, Stephan Brand, et al.
Plos One|February 1, 2013
IRGM variants and susceptibility to inflammatory bowel disease in the German populationJürgen Glas, Julia Seiderer, Stephanie Bues, et al.
Science (New York, N.Y.)|January 18, 2005
CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearanceJan Hendrik Niess, Stephan Brand, Xiubin Gu, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 22, 2008
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptorsMartin A Storr, Catherine M Keenan, Dominik Emmerdinger, et al.
The American Journal of Gastroenterology|May 21, 2009
Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's diseaseHelga P Török, Jürgen Glas, Ilona Endres, et al.
Inflammatory Bowel Diseases|December 20, 2007
Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBDJulia Seiderer, Ira Elben, Julia Diegelmann, et al.
Clinical Immunology (Orlando, Fla.)|February 6, 2008
Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel diseaseJulia Seiderer, Julia Dambacher, Dorothea Leistner, et al.
Pageof 17

Showing results (111-120 of 163) with videos related to

Sort By:
Pageof 17
Pharmacoepidemiology and Drug Safety|May 3, 2014
Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodiesFlorian Beigel, Anni Steinborn, Fabian Schnitzler, et al.
Scientific Reports|June 20, 2025
CCL20 expression is elevated in inflammatory bowel disease and attenuated by vitamin D metabolitesJohannes Stallhofer, Felix Reichl, Michael Lauseker, et al.
Journal of Crohn'S & Colitis|June 28, 2020
Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should knowPhilipp Schreiner, Nicolas J Mueller, Jan Fehr, et al.
United European Gastroenterology Journal|September 9, 2024
Fecal urgency and incontinence in inflammatory bowel disease perceived by physician and patient: Results from the Swiss fecal urgency surveyNadia Wespi, Stephan Vavricka, Stephan Brand, et al.
Plos One|February 1, 2013
IRGM variants and susceptibility to inflammatory bowel disease in the German populationJürgen Glas, Julia Seiderer, Stephanie Bues, et al.
Science (New York, N.Y.)|January 18, 2005
CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearanceJan Hendrik Niess, Stephan Brand, Xiubin Gu, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 22, 2008
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptorsMartin A Storr, Catherine M Keenan, Dominik Emmerdinger, et al.
The American Journal of Gastroenterology|May 21, 2009
Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's diseaseHelga P Török, Jürgen Glas, Ilona Endres, et al.
Inflammatory Bowel Diseases|December 20, 2007
Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBDJulia Seiderer, Ira Elben, Julia Diegelmann, et al.
Clinical Immunology (Orlando, Fla.)|February 6, 2008
Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel diseaseJulia Seiderer, Julia Dambacher, Dorothea Leistner, et al.
Pageof 17